Money
Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals....
Hi, what are you looking for?
Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals....
Of course, one can always find ways to track buys and sells from guru hedge fund managers, but there are exchange traded funds that...
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
Steven Mandel’s Greenwich, Connecticut-based Lone Pine Capital has 67 holdings worth $24.7 billion, and the fund’s value increased 1.08% in the second quarter. Mandel...
– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. – The shares of three Israeli biomedical companies that...
– If a meeting is called, Ackman and Pearson would be expected to try to utilize it to vote in a new slate of directors. –...
– Lawyers for Allergan, Valeant Pharmaceuticals and Pershing Square yesterday announced they had mutually agreed to a common understanding, without waiting for a...
– – 2013 was a positive year for Israeli high-tech and biotech, in almost every respect: total investments rose, salaries rose, and there were...
– Why ? Because : “Israel took third place in the “Innovation” category in the latest Global Competitiveness Ranking published by the World Economic Forum....
– Phillip Frost: What Israel needs today is 10 companies like Teva; one is not enough. – Phillip Frost / Getty – / By...